Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gynecological Cancer-Related Anemia Mechanism and Treatment Strategies
ChiCTR-IPR-16009059Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Sep 2016
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of epoetin alfa and Iron in cancer-associated anemia (CRA) and gynecological cancer (5 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Started Sep 2016; status: recruiting.
02
Drugs
epoetin alfaIron
03
Conditions
cancer-associated anemia (CRA)gynecological cancer
Beyond the preview
Go deeper on ChiCTR-IPR-16009059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16009059.